 The purpose of this study is to assess the tolerability, adherence and efficacy of single tablet dolutegravirabacavirlamivudine antiretroviral therapy in people living with HIV with a history of injection drug use IDU switching from existing antiretroviral therapy ART or starting treatment after discontinuation of ART. 